Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00027144 · ClinicalTrials.gov registry record · Phase 1
Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase
A Phase 1 study of Leukemia,Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive, sponsored by University of Connecticut.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
- 1
- Study location
NCT00027144 is a Phase 1 study of Leukemia,Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive that has completed, run by University of Connecticut. The registered enrollment target is 10 participants. The trial reports 1 study location across 1 state.
The verdict
NCT00027144, a Phase 1 study of Leukemia,Myeloid, Chronic and Leukemia,Myeloid,Philadelphia-Positive, has completed, sponsored by University of Connecticut.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
- 1
- Study location
Study Summary
Description: The trial is designed to determine the response of the immune system of patients with CML to a vaccine made from their own tumor. Researchers believe that this particular vaccine, which is made from purified heat shock proteins taken from each patient's tumor, alerts the body's immune system to recognize and attack invading cancer. To be considered potentially eligible for this study you must have CML in the chronic phase. Length/Duration: Vaccinations will be administered weekly for eight weeks. One clinic follow up visit will be scheduled two weeks after the final vaccination.
Conditions Studied
Interventions
- BIOLOGICAL Heat Shock Protein 70 HSP70
Study Locations (1)
Connecticut
- University of Connecticut Health Center - Farmington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2000-12 |
| Est. Completion | 2002-10 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00027144
The ClinicalTrials.gov registry entry for NCT00027144 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Connecticut, which has 107 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Leukemia,Myeloid, Chronic appearing as the primary indexed condition, and to 1 intervention - of which Heat Shock Protein 70 HSP70 is the first listed.
NCT00027144 reports 1 study location spanning 1 distinct geographic area - top geographies include Connecticut.
Frequently Asked Questions
What is clinical trial NCT00027144 about?
NCT00027144 is a clinical study titled "Study Using Vaccination With Heat Shock Protein 70 (HSP70) for the Treatment of CML in Chronic Phase". Description: The trial is designed to determine the response of the immune system of patients with CML to a vaccine made from their own tumor. Researchers believe that this particular vaccine, which is made from purified heat shock proteins taken from each patient's tumor, alerts the body's immune s...
What is the current status of trial NCT00027144?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2000-12. Estimated completion is 2002-10.
What conditions does trial NCT00027144 study?
This clinical trial studies the following conditions: Leukemia,Myeloid, Chronic, Leukemia,Myeloid,Philadelphia-Positive.
What interventions are being tested in trial NCT00027144?
The interventions under investigation include: Heat Shock Protein 70 HSP70 (BIOLOGICAL).
Who is sponsoring clinical trial NCT00027144?
This trial is sponsored by University of Connecticut, which has 107 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00027144 being conducted?
This trial has 1 study location across Connecticut. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Leukemia,Myeloid, Chronic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Explore more on PlainTrial
Leukemia,Myeloid, Chronic
All registered trials for this condition
Leukemia,Myeloid,Philadelphia-Positive
All registered trials for this condition
Connecticut
All trials with a study site in Connecticut
Recruiting now
Find trials open to new participants near you
Rankings
Top sponsors, conditions, and phases
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.